Zhengyu Jiang

39PUBLICATIONS
13CO-AUTHORS
Molecular targetsImmunogenetics (incl. genetic immunology)Gene and molecular therapyClinical pharmacology and therapeuticsSupramolecular chemistry
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (39)

|Aug 27, 2026
Harnessing the E3 Ligase KLHL12 for Tumor-Selective Protein Degradation.

|Jul 15, 2026
Identification of Pyrrolo [2,3-b] Pyridine Derivatives as Novel JAK1 Inhibitors for the Treatment of Inflammatory Bowel Disease.

|May 30, 2026
Discovery of a Biased Kelch-like ECH-Associated Protein 1-p62 (Keap1-p62) Protein-Protein Interaction (PPI) Inhibitor for the Management of p62 Aberrant Hepatocellular Carcinoma.

|Mar 31, 2026
Discovery of a Prodrug of Bardoxolone Methyl for the Treatment of Acute Lung Injury.

Shuai Wen, Yingping Li, Xi Li

|Feb 27, 2026
Scaffold Hopping-Guided Design of Novel PIM-1 Inhibitors with Anticancer Activities.

Yabing Xin, Qian Wu, Yitong Gao

|Feb 20, 2026
From Covalent to Supramolecular: Re-Thinking Lysosome-Targeting Chimeras Through Modular and Tunable Proximity Control.

Nan Wang, Xiaoran Wang, Zhengyu Jiang

Pageof 7

Frequent Collaborators

26 joint publications

Qidong You

8 joint publications

Xiaoke Guo

6 joint publications

Xuetao Chen

3 joint publications

Jinglong Zhao